Biologics startup, MiMedx, pulls in $5M in Private Placement

By

MiMedx Group Completes $5,000,000 Private Placement (press release)
MiMedx Group, Inc.  (OTCBB:MDXG.ob - News), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials including bioimplants processed from human amniotic membrane, announced today that the Company's $5,000,000 private placement offering to sell common stock and warrants has been over-subscribed.
From the commencement of the offering on October 30, 2010, through June 30, 2011, the Company sold approximately 6,545,000 shares of common stock at a price of $1.00 per share and received procee...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.